Changes in signaling pathways of cell proliferation and apoptosis during NK/Ly lymphoma aging

Cell Biology International - Tập 32 - Trang 1057-1063 - 2008
R.R. Panchuk1, N.M. Boiko1, M.D. Lootsik1, R.S. Stoika1
1Institute of Cell Biology, National Academy of Sciences of Ukraine, Drahomanov Str. 14/16, 79005 Lviv, Ukraine

Tóm tắt

AbstractExpression of specific proteins involved in regulation of cell proliferation and apoptosis was studied at the initial (7–8 days after tumor inoculation), median (13–14 days), and terminal (20–21 days) stages of murine NK/Ly lymphoma development. Western‐blot analysis using antibodies to MEK—ERK signaling pathway, E2F‐1/2 and c‐Myc, pSTAT1, pSTAT3, pSTAT5, anti‐apoptotic Bcl‐XL and pro‐apoptotic p53 and Rb proteins, as well as active cleaved forms of caspases‐3, −6, −7, was carried out to investigate the growth and survival status of NK/Ly cells. There was a marked increase in the expression of E2F‐1/2 transcription factors, MAPK signaling cascade and c‐Myc, which suggests intensive proliferation of lymphoma cells at terminal stage of tumor development. However, cytomorphological investigation and electrophoretic study of DNA fragmentation have shown degeneration of NK/Ly lymphoma cells and increase in their death. No expression of p53 protein or cleaved forms of caspases‐3, −6, −7 was found, which suggests a caspase‐independent type of apoptosis in these cells. Ascitic fluid collected at a terminal stage of NK/Ly lymphoma development was significantly weaker in supporting tumor cell growth than ascitic fluid collected at the initial stage of tumor development. It is suggested that uncontrolled cell proliferation at terminal stage of the NK/Ly lymphoma development causes nutrient deprivation and deficiency of specific growth factors in the ascitic fluid, due to overexpression of MEK—ERK, E2F and c‐Myc, thereby leading to the induction of apoptosis.

Tài liệu tham khảo

Bergmeyer H.U., 1983, Methods of enzymatic analysis, 574 10.1038/sj.onc.1203481 10.1186/1475-2867-1-1 10.1016/j.cellbi.2008.06.003 10.1182/blood.V97.2.483 10.1016/j.tibs.2004.09.008 10.1016/j.uct.2006.04.004 10.1182/blood.V86.4.1243.bloodjournal8641243 10.1016/0014-2964(78)90139-1 10.1016/0014-2964(78)90140-8 Kurnatowski A., 1961, Cytochemistry of the NK/Ly lymphoma, Nature, 4886, 1211 10.1038/sj.onc.1203486 10.1038/sj.onc.1203495 10.4161/cc.2.4.428 10.1101/gad.10.20.2621 10.1023/A:1009697908332 Nemeth L., 1961, A new mouse ascites tumor to be used as screening tool, Neoplasma, 8, 337 10.2478/s11535-007-0011-4 10.1074/jbc.273.13.7770 10.1016/0003-2697(77)90043-4 10.1016/j.cellbi.2008.04.021 10.1186/1475-2867-6-25 10.1038/sj.onc.1210422 10.1073/pnas.0931260100 Schott A.F., 1995, Bcl‐xL protects cancer cells from p53‐mediated apoptosis, Oncogene, 11, 1389 10.1126/science.123.3191.309 Wheatley D., 2006, Regrowth of tumour cells from supposedly terminal giant cells, Oncol News, 1, 3
Thông tin
Thông tin xuất bản

Cell Biology International

Tập 32

1057-1063

Thông tin tác giả